Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
Clinical trial NCT06600841 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06600841
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2026-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.